BYE-LAWS IN TERMS OF THE GENERAL REGULATIONS FOR UNIVERSITY POSTGRADUATE AWARDS, 2008 FOR THE DEGREE

MASTER OF SCIENCE IN DIABETES CARE - M.SC

SUBSIDIARY LEGISLATION 327.595

BYE-LAWS IN TERMS OF THE

GENERAL REGULATIONS FOR UNIVERSITY

POSTGRADUATE AWARDS, 2008 FOR THE DEGREE

OF MASTER OF SCIENCE IN DIABETES CARE - M.SC.

- UNDER THE AUSPICES OF THE FACULTY OF

HEALTH SCIENCES AND THE FACULTY OF

MEDICINE AND SURGERY

28th June, 2018

LEGAL NOTICE 207 of 2018, as amended by Legal Notice 310 of

2019.

(1)

These bye-laws may be cited as the Bye-Laws in

terms of the General Regulations for University Postgraduate

Awards, 2008 for the Degree of Master of Science in Diabetes Care -

M.Sc. - under the auspices of the Faculty of Health Sciences and the

Faculty of Medicine and Surgery.

(2)

In these bye-laws, unless the context otherwise requires -

“the Boards” means the Board of the Faculty of Health Sciences

and the Board of the Faculty of Medicine and Surgery;

“the Board of Studies” means the Board of Studies appointed by

Senate for the Course on the recommendations of the Boards of the

Faculty of Health Sciences and the Faculty of Medicine and Surgery;

“the Course” means the programme of study leading to the

degree of Master of Science in Diabetes Care - M.Sc.;

“the Degree” means the degree of Master of Science in Diabetes

Care - M.Sc.;

“the Postgraduate Certificate” means the Postgraduate

Certificate in Diabetes Care – P.G. Cert.;

“the Postgraduate Diploma” means the Postgraduate Diploma in

Diabetes Care – P.G. Dip.; and

“the Principal Regulations” means the General Regulations for

University Postgraduate Awards, 2008.

These bye-laws shall be

applicable

for

courses

commencing in October 2019 or later.

MASTER OF SCIENCE IN DIABETES CARE - M.SC

(1)

The Course shall be open to applicants in possession

of

(a)

the degree of Doctor of Medicine and Surgery; or

(b)

the degree of Bachelor of Dental Surgery; or

(c)

the degree of Master of Dental Surgery awarded

from July 2018 onwards; or

(d)

the degree of Bachelor of Pharmacy (Honours) with

at least Second Class; or

(e)

the degree of Master of Pharmacy; or

(f)

the degree of Bachelor of Science (Honours)

obtained with at least Second Class in an area of

study deemed suitable by the Board of Studies; or

(g)

a qualification deemed by Senate, on the

recommendation of the Board of Studies, to be

equivalent to the qualifications listed in (a) to (f)

above.

(2)

The Boards shall recommend to Senate the number of

applicants that may be allowed to register for the Course, depending

on the availability of resources. The Boards shall announce the

number of available places at the time of the call for applications.

(3)

When the number of places is so limited and the number of

eligible applicants exceeds the number of places available, applicants

shall be selected using the following criteria, the weighting of which

shall be published at the time of the call for applications

(a)

degree class;

(b)

experience in the area of the proposed study; and

(c)

performance during an interview, if deemed

necessary.

(4)

Interviews, if necessary, shall be conducted by a board

composed of at least three members appointed for the purpose by the

Boards.

(5)

For the purpose of selection, applicants who fully satisfy

the entry requirements by 31st August preceding the commencement

of the Course shall be considered first.

(6)

During the first year of the Course, accepted students shall

MASTER OF SCIENCE IN DIABETES CARE - M.SC

be required to undergo an occupational health assessment so as to

ascertain that they are fit to undertake work related to clinical

placements. Students who do not fulfil this requirement may be barred

from progressing with their studies. Failure to disclose information

about a physical or mental health problem that could affect patient

safety is considered to be a serious breach of the University Suitability

to Practise Regulations.

The Course shall extend over three years of part-time

study.

(1)

The academic administration of the Course shall be

entrusted to a Board of Studies appointed for the purpose.

(2)

The Board of Studies, which shall be appointed for a

period of two years, shall be composed as follows

(a)

the Dean of the Faculty of Health Sciences and the

Dean of the faculty of Medicine and Surgery or

their respective delegate, one of whom shall be

appointed

as

Chairman

on

the

joint

recommendation of the two Faculties;

(b)

at least two academic members of staff from each

of the two faculties; and

(c)

two students elected from amongst the students

registered on the Course.

The programme of study shall comprise study-units to

which a total of 90 ECTS credits are assigned, of which 60 ECTS

credits are assigned to taught study-units and 30 ECTS credits are

assigned to a dissertation study-unit.

Students who obtain 30 ECTS credits assigned to taught

study-units with an average mark of at least 50% and do not proceed

with the Course, or having proceeded do not successfully complete

the Course, shall be eligible for the award of the Postgraduate

Certificate.

Students who obtain the 60 ECTS credits assigned to the

taught study-units with an average mark of at least 50% and do not

proceed with the Course, or having proceeded do not successfully

complete the dissertation, shall be eligible for the award of the

Postgraduate Diploma.

The programme of study shall be published after approval

by Senate, normally not less than eight months prior to the

commencement of the Course.

(1)

The assessment of each taught study-unit shall be

completed by the end of the semester in which the teaching of the

MASTER OF SCIENCE IN DIABETES CARE - M.SC

study-unit is held.

(2)

Students who in any academic year fail in the assessment

of not more than 10 ECTS credits shall be given the opportunity to re-

sit the failed assessments during the September supplementary

examination session.

(3)

Students who fail in more than the number of credits

permitted under paragraph (2) of this bye-law or students who after

re-assessment fail to obtain credit for any study-unit shall be required

to withdraw from the Course

provided that students who fail in a study-unit involving a

clinical placement that requires assessment over a period of time shall

not have the right to a supplementary assessment and shall be required

to withdraw from the Course.

(1)

Students shall be required to submit an individual

dissertation of approximately 15,000 to 20,000 words in accordance

with the guidelines issued by the Board of Studies.

(2)

Work on the dissertation shall be undertaken during the

third year of the Course. Each student shall be assigned a supervisor

who shall provide guidance and advice on a regular basis during the

period of study.

(3)

A provisional title for the dissertation and a detailed

research proposal shall be submitted to the Board of Studies for

approval by the end of third semester.

(1)

Students shall be required to have regular contact

with their supervisor.

(2)

Supervisors shall submit to the Board of Studies progress

reports for each student under their supervision at the end of each

semester of studies. Such reports may include recommendations to

either (a) extend the period of study in order to enable the student to

complete the dissertation; or (b) terminate studies prematurely if the

supervisor deems this to be proper in the circumstances, provided

that

(i)

the extension of the study period referred to in (a)

shall be in accordance with the provisions of

Principal Regulations; and

(ii)

the Board may not terminate studies prematurely

according to (b) until it has first given the student a

chance to be heard.

The Final Weighted Average Mark for the purpose of the

classification of the Postgraduate Diploma and of the Degree shall be

MASTER OF SCIENCE IN DIABETES CARE - M.SC

based on the results obtained in all the components of the programme

of study, all credits being weighted equally.